Is Archit Organosys overvalued or undervalued?

As of 17 October 2025, the valuation grade for Archit Organosys has moved from fair to attractive, indicating a more favorable assessment of its financial position. The company is currently considered undervalued, particularly in light of its PEG ratio of 0.02 and an EV to EBITDA ratio of 18.85, which suggests strong growth potential relative to its earnings before interest, taxes, depreciation, and amortization. Additionally, the PE ratio stands at 154.30, which, while high, reflects the company's growth prospects in the commodity chemicals sector.
In comparison to peers, Archit Organosys has a significantly higher PE ratio than Godrej Industries, which has a PE of 36.08, and a much lower PEG ratio compared to Solar Industries at 2.77. This positions Archit Organosys favorably within its industry, despite its high PE ratio. Notably, the company's recent stock performance has lagged behind the Sensex, especially in the one-month and year-to-date periods, but its five-year return of 217.16% indicates substantial long-term growth potential.